Friday, October 25, 2013 11:27:10 AM
Well, I don't know what they really have and don't have. But, if I were PPHM and I had what I think they have, I'd do the following in the next 6 mos. to improve stock price.
1. I'd start the phase III bavi trial, announce the expectation of rapid enrollment since they are using sites already trained in the phase II trial. I'd also put out a PR piece reminding potential patients of the impressive results obtained in Phase II.
2. I'd continue to recruit KOL's to the anti-PS IT theme to help sell the industry. And, I'd employ the KOL's at every possible marketing event similar to Sydney to help get the word out. I'd also utilize the KOL's to help me attract the biggest and baddest deal-maker in the biotech space.
3. I'd publish the pre-clinical data from the IT combo trials and combine the data press release with a massive PR push to educate potential investors on the emerging role of IT combo's in cancer treatment as well as anti-PS's role as a "global" checkpoint in this fight.
4. Once patent paperwork was squared away, I'd release pre-clinical data on the next generation of anti-Ps (betabodies). I'd do this to demonstrate to investors and potential partners about the breadth of the anti-Ps platform. And, I'd stress the "platform" point to the market at every chance.
5. I'd have PR programs ready to roll to coincide with Liver and Breast IST data publication. I'd stress the whole portfolio of bavi clinical work especially pointing out the continued, consistent safety profile and I'd have the scientist expound on the universal basic science of PS and it's role against numerous forms of cancer.
6. I'd announce that I'd hired the biggest and baddest deal-maker/financier in the biotech space and tell the market that this bad boy is helping us look at options, develop our partnering/collaboration opportunities, etc.
7. I'd close additional Avid opportunities and look to utilize Avid to procure asset based bridge loans to get us to the partnership we want.
8. I'd have PR develop a program to tell the investment world about the wonders of anti-PS and I'd not limit it to the institutional dog and pony shows. I'd piggy back on the great PR BMS and Roche have done to sell the coming dawn of the IT revolution. And, I'd hand a copy of the Citi research report that project great things for IT to everyone I talked to.
9. Upon dismissal of the class action lawsuit, I'd issue a PR telling investors what I know and do not know about the "dose switching" incident and include steps being taken to assure this never happens again. Many would choose just to move on, but with PPHM, I'd think it would be crucial to help gain back lost trust.
10. I'd settle the CSM lawsuit for whatever value initial depositions indicate is available via CSM's insurance carrier.
Please understand, I don't know where PPHM stands with any of these items or even if they have the goods. Just an educated guess that they do indeed have some of them. Educate the industry and investors. Add the right folks to team PPHM indicating a deal(s) will be struck, continue to improve the financial performance of Avid, and sell, sell, sell your story. That ought to do some good. For a company like PPHM that is valued so horribly against industry comparables, good news should equate to correspondingly better reactions.
Regards,
WH
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 11:40:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:38:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/11/2024 11:37:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:22:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 12:21:22 AM
- Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference • GlobeNewswire Inc. • 09/12/2024 08:05:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/09/2024 08:43:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:19:30 PM
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 • GlobeNewswire Inc. • 09/09/2024 08:05:31 PM
- U.S. Futures Rise Amid Inflation Report Anticipation; Oil Prices Climb on Hurricane Threat and Supply Concerns • IH Market News • 09/09/2024 10:09:14 AM
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 • GlobeNewswire Inc. • 09/03/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 08:30:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/28/2024 08:34:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2024 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM